[Federal Register Volume 83, Number 159 (Thursday, August 16, 2018)]
[Notices]
[Pages 40774-40775]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-17617]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Meeting of the Advisory Committee on Blood and Tissue Safety and
Availability
AGENCY: Department of Health and Human Services, Office of the
Secretary, Office of the Assistant Secretary for Health.
[[Page 40775]]
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: As stipulated by the Federal Advisory Committee Act, the U.S.
Department of Health and Human Services is hereby giving notice that
the Advisory Committee on Blood and Tissue Safety and Availability
(ACBTSA) will hold a meeting. The meeting will be open to the public.
DATES: The meeting will take place on Thursday, September 13, 2018,
from 8:00 a.m.-5:00 p.m. ET.
ADDRESSES: Crystal City Marriott at Reagan National Airport, 1999
Jefferson Davis Highway, Arlington, VA 22202.
FOR FURTHER INFORMATION CONTACT: Mr. James Berger, Designated Federal
Officer for the ACBTSA, Senior Advisor for Blood and Tissue Policy,
Office of the Assistant Secretary for Health, Department of Health and
Human Services, Mary E. Switzer Building, 330 C Street SW, Suite L100,
Washington, DC 20024. Phone: (202) 795-7697; Fax: (202) 691-2102;
Email: [email protected].
SUPPLEMENTARY INFORMATION: The ACBTSA provides advice to the Secretary
through the Assistant Secretary for Health. The Committee advises on a
range of policy issues to include: (1) Identification of public health
issues through surveillance of blood and tissue safety issues with
national biovigilance data tools; (2) identification of public health
issues that affect availability of blood, blood products, and tissues;
(3) broad public health, ethical, and legal issues related to the
safety of blood, blood products, and tissues; (4) the impact of various
economic factors (e.g., product cost and supply) on safety and
availability of blood, blood products, and tissues; (5) risk
communications related to blood transfusion and tissue transplantation;
and (6) identification of infectious disease transmission issues for
blood, organs, blood stem cells and tissues. The Committee has met
regularly since its establishment in 1997. The Committee will meet on
September 13, 2018 to receive presentations on material pertinent to
exploring the topic of ``Defining a tolerable risk for infectious
diseases from a patient's perspective.'' Historical aspects of
combating infectious disease risks in the blood supply, ongoing
national and global efforts towards mitigating those risks, and
emerging considerations shall be presented to the Committee. The full
Committee will receive an interim report from the ACBTSA Blood
Sustainability subcommittee and additional topics that are pertinent to
the mission of the Committee may be added to the agenda.
The public will have an opportunity to present their views to the
Committee during public comment session scheduled for the meeting.
Comments will be limited to five minutes per speaker and must be
pertinent to the discussion. Pre-registration is required for
participation in the public comment session. Any member of the public
who would like to participate in this session is required to submit
their name, email, and comment summary prior to close of business on
September 7, 2018. If it is not possible to provide 30 copies of the
material to be distributed at the meeting, then individuals are
requested to provide a minimum of one (1) copy of the document(s) to be
distributed prior to the close of business on September 7, 2018. It is
also requested that any member of the public who wishes to provide
comments to the Committee utilizing electronic data projection submit
the necessary material to the Designated Federal Officer prior to the
close of business on September 7, 2018.
Dated: August 9, 2018.
James J. Berger,
Senior Advisor for Blood and Tissue Policy.
[FR Doc. 2018-17617 Filed 8-15-18; 8:45 am]
BILLING CODE 4150-41-P